ArticleMedical & biological engineering & computing2023
CML-Cardio: a cascade machine learning model to predict cardiovascular disease risk as a primary prevention strategy.
Article in Medical & biological engineering & computing, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CARDPSoML: Comparative approach to analyze and predict cardiovascular disease based on medical report data and feature fusion approach.Health science reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases are among the leading causes of mortality worldwide, with more than 23 million related deaths per year by 2030, according to the World Heart Federation. Although most of these diseases may be prevented, population awareness strategies are still ineffective. In this context, we propose the CML-Cardio tool, a machine learning application to automate the risk classification process of developing CVDs. For this, researchers in our group collected data on diabetes, blood pressure, and other risk factors in a private company. Our final model consists of a cascade system to handle highly imbalanced data. In the first stage, a binary model is responsible for predicting whether a patient has a low risk of developing CVDs or if has a risk that needs attention. In this step, we use six algorithms: logistic regression, SVM, random forest, XGBoost, CatBoost, and multilayer perceptron. The better results presented an average accuracy of 0.86 ± 0.03 and f-score of 0.85 ± 0.04. We interpret each feature's impact on the models' output and validate the subsystem for the next step. In the second stage, we use an anomaly detection model to learn the intermediate risk patterns present in the instances that need attention. The cascade model presented an average accuracy of 0.80 ± 0.07 and f-score of 0.70 ± 0.07. Finally, we develop the CML-Cardio prototype of an actual application as a primary prevention strategy. Graphical abstract In this work, we propose the CML-Cardio tool, a cascade machine learning method to classify cardiovascular disease risk.
Indexed as
Identifiers
36719564What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.